Cargando…
Association between the prolonged use of magnesium sulfate for tocolysis and fracture risk among infants
In 2013, the U.S. Food and Drug Administration issued a safety warning that cautioned against using magnesium sulfate (MgSO(4)) injections for more than 5 to 7 days to stop preterm delivery due to the bone problems subsequently observed in infants. However, the warning was mainly based on case repor...
Autores principales: | Wen, Yung-Hsiang, Wang, I-Te, Lin, Fang-Ju, Hsu, Hsing-Yu, Wu, Chung-Hsuen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701460/ https://www.ncbi.nlm.nih.gov/pubmed/34941123 http://dx.doi.org/10.1097/MD.0000000000028310 |
Ejemplares similares
-
Tocolysis and the risk of nonreassuring fetal status among pregnant women in labor: Findings from a population-based retrospective cohort study
por: Wang, I-Te, et al.
Publicado: (2019) -
Risks and Benefits of Magnesium Sulfate Tocolysis in Preterm Labor (PTL)
por: Elliott, John P., et al.
Publicado: (2016) -
Prevalence, trends, and characteristics of polypharmacy among US pregnant women aged 15 to 44 years: NHANES 1999 to 2016
por: Chang, Yu-Chien, et al.
Publicado: (2023) -
Long-Term Tocolysis With Magnesium Sulfate as a Risk Factor for Low Bone Mass: A Case Series
por: Iio, Kazuaki, et al.
Publicado: (2022) -
Comparison of outcomes following intravenous magnesium compared with intravenous labetalol and oral nifedipine in 355 pregnant Han Chinese women with preeclampsia
por: Peng, Zhouli, et al.
Publicado: (2023)